Emergent BioSolutions (EBS) Interest & Investment Income (2011 - 2018)

Emergent BioSolutions' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $701000.0 for Q3 2018.

• On a quarterly basis, Interest & Investment Income rose 10.05% year-over-year to $701000.0 in Q3 2018; TTM through Sep 2018 was $1.4 million, a 26.2% decrease from a year earlier, with the FY2017 full-year figure at $1.8 million, up 66.48% from the prior year.
• Interest & Investment Income improved to $701000.0 in Q3 2018 per EBS's latest filing, from $306000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $2.7 million in Q4 2014 and bottomed at $31000.0 in Q2 2014.
• The 5-year median for Interest & Investment Income is $222000.0 (2018), against an average of $393947.4.
• Across the five-year window, Interest & Investment Income jumped 15172.22% in 2014 and sank 95.89% in 2015, its largest moves.
• Year by year, Interest & Investment Income stood at $2.7 million in 2014, then sank by 95.89% to $113000.0 in 2015, then jumped by 155.75% to $289000.0 in 2016, then tumbled by 44.64% to $160000.0 in 2017, then soared by 338.12% to $701000.0 in 2018.
• Per Business Quant, the three latest EBS Interest & Investment Income figures stand at $701000.0 (Q3 2018), $306000.0 (Q2 2018), and $222000.0 (Q1 2018).